Krebs Biochemicals & Industries Limited — Quarterly Results & Earnings

₹39.75

-6.96%

Profit Growth YoY-6.60%Latest quarter

Sales Growth YoY-67.57%Latest quarter

Sales CAGR 5Y5.33%5 year compound

Profit CAGR 5Y1.23%5 year compound

📋

Quarterly Performance

YoY Profit Growth-6.60%

⚠️ Mild contraction

YoY Sales Growth-67.57%

🔴 Significant decline

OPM 5Y Average

Operating profit margin

-35.14%

EPS Growth 5Y

4.02%

Interest Coverage

Higher = safer debt servicing

-3.19

ROE

N/A

ROCE

-30.09%

💡

Growth Analysis

Krebs Biochemicals & Industries Limited reported YoY profit growth of -6.60% and revenue growth of -67.57% in the latest quarter. Mild profit contraction — investigate if one-time or structural. Over 5 years, sales compounded at 5.33% and profits at 1.23% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Krebs Biochemicals & Industries Limited

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.